ストックスクリーナーアプリを入手
0.20
0.99%
-0.002
アフターアワーズ：
.19
-0.01
-5.00%
前日終値:
$0.202
開ける：
$0.1922
24時間の取引高:
7.43M
Relative Volume:
0.72
時価総額：
$27.11M
収益：
$1.47M
当期純損益:
$-23.06M
株価収益率:
-0.8795
EPS:
-0.2274
ネットキャッシュフロー:
$-19.64M
1週間 パフォーマンス:
+4.55%
1か月 パフォーマンス:
-6.10%
6か月 パフォーマンス:
-67.85%
1年 パフォーマンス:
-61.43%
1日の値動き範囲:
$0.1856
$0.20
1週間の範囲:
$0.18
$0.2059
52週間の値動き範囲:
$0.17
$0.94
VolitionRX Ltd Stock (VNRX) Company Profile
名前
VolitionRX Ltd
セクター
電話
646 650 1351
住所
No. 24-05 Shaw Centre, 1 Scotts Road, Singapore, TX
Compare VNRX vs TMO, DHR, IDXX, A, WAT
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VNRX
VolitionRX Ltd
|
0.20 | 27.38M | 1.47M | -23.06M | -19.64M | -0.2274 |
TMO
Thermo Fisher Scientific Inc
|
494.54 | 182.60B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
190.79 | 134.18B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
564.66 | 44.63B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
114.54 | 32.21B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
299.89 | 29.21B | 3.17B | 642.63M | 516.49M | 10.77 |
VolitionRX Ltd Stock (VNRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-08 | 開始されました | H.C. Wainwright | Buy |
| 2023-02-01 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2022-02-17 | 再開されました | Cantor Fitzgerald | Overweight |
| 2021-03-10 | 開始されました | Cantor Fitzgerald | Overweight |
| 2018-05-16 | 開始されました | Maxim Group | Buy |
| 2018-05-14 | 繰り返されました | The Benchmark Company | Buy |
| 2016-09-07 | 繰り返されました | Rodman & Renshaw | Buy |
| 2016-02-01 | 開始されました | Rodman & Renshaw | Buy |
すべてを表示
VolitionRX Ltd (VNRX) 最新ニュース
VolitionRx (NYSE: VNRX) wins approval for major share issue and reverse split - Stock Titan
Earnings call transcript: VolitionRx Q4 2025 reveals mixed financial results - investing.com
VolitionRx : Corporate Presentation April 2026 - marketscreener.com
Volitionrx Ltd earnings beat, revenue fell short of estimates - in.investing.com
Volitionrx Ltd earnings beat, revenue fell short of estimates By Investing.com - ca.investing.com
VolitionRX: Q4 Earnings Snapshot - theheraldreview.com
VolitionRX (VNRX) Rating Maintained as Buy by D. Boral Capital | - gurufocus.com
VolitionRx (NYSE: VNRX) details going concern risk, funding needs and Nu.Q® rollout - Stock Titan
Volition says its tests are nearing hospital use in lung cancer and sepsis - Stock Titan
VolitionRX Price Target Maintained With a $3.00/Share by D. Boral Capital - Moomoo
VolitionRX Ltd (VNRX) Q4 2025: Everything You Need to Know Ahead of Earnings - gurufocus.com
VolitionRx Secures EUR 2.0 Million of Non-Dilutive Funding from Regional Government Agencies in Belgium - Yahoo Finance Singapore
VolitionRx biomarkers show elevation in trauma patients study By Investing.com - Investing.com Australia
VolitionRx biomarkers show elevation in trauma patients study - investing.com
A blood test before lung surgery helped flag higher-risk patients - Stock Titan
VolitionRx to outline 2025 results and milestones on April 1 - Stock Titan
VolitionRx Limited (VNRX) Stock: Rallies on Promising Multi-Cancer Early Detection Breakthrough - parameter.io
Blood test detects 95% of stage I and II cancers in blinded study - Stock Titan
VNRX Stock Price, Quote & Chart | VOLITIONRX LTD (NYSEARCA:VNRX) - chartmill.com
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
VNRX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
VolitionRx (NYSE: VNRX) CCO shares withheld and cancelled for RSU taxes - Stock Titan
Tax withholding reduces VolitionRx (NYSE: VNRX) secretary’s share count - Stock Titan
VolitionRx (VNRX) CSO uses 5,310 shares to cover tax bill - Stock Titan
VolitionRx (VNRX) GC has 7,003 shares cancelled for tax withholding - Stock Titan
In today's session, these stocks are experiencing unusual volume. - ChartMill
VNRX Receives Unchanged 'Buy' Rating from D. Boral Capital | VNR - GuruFocus
VolitionRX Ltd (VNRX) Stock Price, Quote, News & History - Benzinga
VolitionRx Limited (VNRX) Stock: Jumps on World-First Cancer DNA Isolation Breakthrough - parameter.io
These stocks are the most active in today's session - ChartMill
Stock Market Volume Leaders: Nasdaq, NYSE, and NYSE American Trading ActivityNews and Statistics - IndexBox
Aug Drivers: What is the cash position of VolitionRx Limited2026 Biggest Moves & High Accuracy Swing Trade Signals - baoquankhu1.vn
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
VolitionRx (VNRX) Stock Soars 70% on Revolutionary Cancer DNA Discovery - Blockonomi
VolitionRx (VNRX) Stock Soars 70% on Liquid Biopsy Breakthrough - parameter.io
VolitionRx (VNRX) Stock Soars 70% on Revolutionary Cancer DNA Detection Method - MoneyCheck
VolitionRx (VNRX) Stock Surges 70% After Cancer DNA Breakthrough - CoinCentral
New liquid biopsy from VolitionRx finds 49 of 49 cancers in early study - Stock Titan
VolitionRx Ltd Stock (ISIN: US92852X1037) Faces Prolonged Uncertainty Amid Diagnostics Stagnation - AD HOC NEWS
VolitionRX (VNRX) Stock Price, News & Analysis - MarketBeat
VolitionRX: Navigating the Path from Innovation to Market Adoption () - aktiencheck.de
VolitionRx announces automated Nu.Q Vet Cancer Test with Fujifilm Vet Systems - Yahoo Finance
VolitionRx shares jump as feline cancer blood test delivers strong accuracy results - MSN
VolitionRx (VNRX) Completes Key Phase for Nu.Q Vet Cancer Test i - GuruFocus
Volition announces first ever automated Nu.Q® Vet cancer test with Fujifilm Vet Systems - marketscreener.com
Automated cancer screening test set for Japan’s 7M pet dogs - Stock Titan
Tax withholding on VolitionRx (VNRX) shares for officer via RSU settlement - Stock Titan
VolitionRx (VNRX) CCO covers tax bill via 2,283-share cancellation - Stock Titan
Tax withholding trims VolitionRx (VNRX) GC Nicholas Plummer’s shares - Stock Titan
VNRX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
AIFF PE Ratio & Valuation, Is AIFF Overvalued - Intellectia AI
VolitionRX Ltd (VNRX) 財務データ
収益
当期純利益
現金流量
EPS
0.87%
大文字化:
|
ボリューム (24 時間):